| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | A systematic review of sevelamer in ESRD and an analysis of its potential economic impact in Canada and the United States. | Kidney Int | 2004 | 2.29 |
| 2 | A systematic review of cost-sharing strategies used within publicly-funded drug plans in member countries of the organisation for economic co-operation and development. | PLoS One | 2014 | 0.87 |
| 3 | A synthesis of drug reimbursement decision-making processes in organisation for economic co-operation and development countries. | Value Health | 2014 | 0.82 |
| 4 | Health Care Costs Associated with AKI. | Clin J Am Soc Nephrol | 2017 | 0.75 |